Article Information
History
- March 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Samantha Bents1,*,
- Cécile Viboud2,
- Bryan Grenfell1,
- Alexandra Hogan3,
- Stefano Tempia4,5,
- Anne von Gottberg4,7,8,
- Jocelyn Moyes4,5,
- Sibongile Walaza4,5,
- Cheryl Cohen4,5 and
- Rachel Baker6
- 1Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA
- 2Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States
- 3School of Population Health, University of New South Wales, Sydney, New South Wales, Australia
- 4Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
- 5School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
- 6Princeton Environmental Institute, Princeton University, Princeton, NJ, USA
- 7School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
- 8Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- ↵* Corresponding author; email: sbents{at}princeton.edu
Posted March 13, 2022.
The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa
